Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Oxford Cannabinoid Technologies collaborate with Dalriada to expand into other therapeutic areas

Oxford Cannabinoid Technologies collaborate with Dalriada to expand into other therapeutic areas

Valentino Parravicini , Oxford Cannabinoid Tech, the Chief Scientific Officer joins Proactive London's Katie Pilbeam to talk about trading on the OTCQB Market, the mid-tier OTC Equity Market in the United States soon.

The firm has also recently brought in the experts to assess the potential of the cannabinoid library licensed from the North American cannabis giant, Canopy Growth. OCT has teamed up with Dalriada, a specialist Canadian group that it will use to “propel R&D activities”.

Dalriada has previously designed, synthesised and experimentally tested all of the compounds in the Canopy library.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK